Tumor Necrosis Factor Ligand Superfamily Member 15
"Tumor Necrosis Factor Ligand Superfamily Member 15" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of tumor necrosis factor superfamily found on ENDOTHELIAL CELLS that plays a role in the inhibition of endothelial cell growth and PHYSIOLOGIC ANGIOGENESIS.
Below are MeSH descriptors whose meaning is more general than "Tumor Necrosis Factor Ligand Superfamily Member 15".
Below are MeSH descriptors whose meaning is more specific than "Tumor Necrosis Factor Ligand Superfamily Member 15".
This graph shows the total number of publications written about "Tumor Necrosis Factor Ligand Superfamily Member 15" by people in Harvard Catalyst Profiles by year, and whether "Tumor Necrosis Factor Ligand Superfamily Member 15" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
Below are the most recent publications written about "Tumor Necrosis Factor Ligand Superfamily Member 15" by people in Profiles.
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis. Inflamm Bowel Dis. 2022 03 02; 28(3):434-446.
Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome. Kidney Int. 2020 11; 98(5):1308-1322.
RORa-expressing T regulatory cells restrain allergic skin inflammation. Sci Immunol. 2018 03 02; 3(21).
Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling. Hum Mol Genet. 2017 11 01; 26(21):4301-4313.
CX3CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014 Jul 28; 211(8):1571-83.
Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors. Angiogenesis. 2011 Mar; 14(1):61-8.
A positive relationship between filamin and VEGF in patients with lung cancer. Anticancer Res. 2010 Oct; 30(10):3939-44.
TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Inflamm Bowel Dis. 2010 Apr; 16(4):568-75.
Sensitization of endothelial cells to VEGI-induced apoptosis by inhibiting the NF-kappaB pathway. Apoptosis. 2009 Jun; 14(6):788-95.
Inhibition of endothelial progenitor cell differentiation by VEGI. Blood. 2009 May 21; 113(21):5352-60.